Working Paper: Global Economic Impacts of Antimicrobial Resistance
SUMMARY
Peterson Institute for International Economics (PIIE) | June 2025
If you're a healthcare professional concerned about antimicrobial resistance (AMR), this working paper by Fernando and McKibbin offers a compelling economic case for action.
Motivated by the fact that antimicrobial resistance is not just a clinical threat but also a major drag to long‑term growth and stability, the authors attempt to quantify the global economic consequences of AMR. Using the G‑Cubed multi-country model, they simulate six scenarios linking AMR to losses in labor productivity, agricultural output, financial risk premia, and increased public spending. Their key insight is that left unchecked, AMR in the face of demographic and climate trends could impose significant economic burdens worldwide — and that investing in a “One Health” strategy to curb resistance offers substantial economic and public health returns.
FEATURED EXPERTS
- Roshen Fernando, World Bank Consultant
- Warwick McKibbin, AO, FASSA, Director, Centre for Applied Macroeconomic Analysis, Australian National University
GET STARTED
Gain a deeper understanding of how early, coordinated AMR intervention could help prevent a global economic crisis.
